News headlines about Neogen Corporation (NASDAQ:NEOG) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neogen Corporation earned a daily sentiment score of 0.12 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 45.5428042071383 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news stories that may have impacted Accern’s rankings:
- Neogen Corporation (NEOG) VP Sells $1,431,623.68 in Stock (americanbankingnews.com)
- Latin America Veterinary Surgical Devices Market Predicted to Reach USD 125.48 million by 2021 (reports.pr-inside.com)
- Veterinary Diagnostics Market by Product, Technology, Animal Type, Application and End User – Global Forecast to 2022 (forextv.com)
- Middle East And Africa Animal Genetics Market estimated to be growing at a CAGR of 8.3%, to reach USD 328.9 million by 2021 (emailwire.com)
- Global Food Safety Testing Markets 2014-2017 & 2022 (bizjournals.com)
Several brokerages have weighed in on NEOG. BidaskClub cut Neogen Corporation from a “buy” rating to a “hold” rating in a report on Friday, August 18th. Zacks Investment Research cut Neogen Corporation from a “buy” rating to a “hold” rating in a report on Friday, August 18th.
Shares of Neogen Corporation (NEOG) traded up $2.60 during midday trading on Tuesday, hitting $84.31. The company had a trading volume of 139,199 shares, compared to its average volume of 111,682. The stock has a market cap of $3,230.00, a PE ratio of 67.55, a P/E/G ratio of 4.09 and a beta of 1.53. Neogen Corporation has a 1 year low of $59.51 and a 1 year high of $84.50.
Neogen Corporation (NASDAQ:NEOG) last issued its quarterly earnings data on Tuesday, September 19th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.01. The firm had revenue of $95.30 million during the quarter, compared to analysts’ expectations of $94.87 million. Neogen Corporation had a return on equity of 9.93% and a net margin of 12.28%. The firm’s quarterly revenue was up 14.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.26 EPS. equities analysts expect that Neogen Corporation will post 1.31 EPS for the current fiscal year.
In related news, VP Edward Bradley sold 38,876 shares of the company’s stock in a transaction dated Wednesday, September 20th. The stock was sold at an average price of $71.28, for a total transaction of $2,771,081.28. Following the transaction, the vice president now directly owns 83,712 shares of the company’s stock, valued at approximately $5,966,991.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Steven J. Quinlan sold 2,250 shares of the company’s stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $78.52, for a total value of $176,670.00. The disclosure for this sale can be found here. Insiders have sold a total of 193,034 shares of company stock valued at $14,717,645 over the last 90 days. 4.20% of the stock is currently owned by company insiders.
Neogen Corporation Company Profile
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corporation and related companies with MarketBeat.com's FREE daily email newsletter.